Evidence map›Paper›PMID 42315775›Full record

ArticleCEN case reports2026

Membranous nephropathy secondary to very early-onset inflammatory bowel disease in a 3-year-old boy: case report.

Shuhei Aoyama, Tomohiko Yamamura, Tomoko Horinouchi, Yuka Kimura, Yuta Inoki, Nana Sakakibara, China Nagano, Shingo Ishimori, Yasuyuki Kameoka, Keisuke Kajihara and 6 more

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shuhei AoyamaDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Tomohiko YamamuraDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan. tomohiko@med.kobe-u.ac.jp.ORCID 0000-0001-6107-1169
Tomoko HorinouchiDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Yuka KimuraDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Yuta InokiDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Nana SakakibaraDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
China NaganoDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Shingo IshimoriDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Yasuyuki KameokaDepartment of Pediatric Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo, Kobe, Hyogo, 650-0017, Japan.
Keisuke KajiharaDepartment of Pediatric Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo, Kobe, Hyogo, 650-0017, Japan.
Harunori MiyauchiDepartment of Pediatric Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo, Kobe, Hyogo, 650-0017, Japan.
Yuna KuDepartment of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.
Haruka MiyazakiDepartment of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.
Norihiro OkamotoDepartment of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.
Norishige YoshikawaClinical Research Center, Takatsuki General Hospital, Takatsuki, Japan.
Kandai NozuDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membranous nephropathy (MN) is uncommon in children overall, but secondary MN is relatively common in younger children. Inflammatory bowel disease (IBD) can be complicated by kidney disease, but IBD complicated by MN is rarely reported. A 3-year-old boy diagnosed with very early onset IBD (VEO-IBD) a year earlier was incidentally found to have proteinuria via urine screening system. Laboratory tests revealed nephrotic syndrome with microscopic hematuria and signs of ongoing inflammation associated with IBD activity. Kidney biopsy showed mesangial cell proliferation and dense subepithelial immune complex deposits, along with negative PLA2R staining, which supported a diagnosis of secondary MN. Oral steroid therapy was initiated for its potential benefit for both nephrotic syndrome and the underlying VEO-IBD. As a result, four months later, proteinuria and hematuria had resolved, and kidney function remained stable. This is the youngest reported patient with MN associated with IBD. Routine urinalysis is suggested by this case to be useful for detecting kidney complications of IBD, including MN. Moreover, steroid therapy is likely to be useful for MN secondary to IBD. Our report suggests that potential kidney complications should also be considered in patients with VEO-IBD.

Indexed as

Glomerulonephritis, MembranousInflammatory Bowel DiseasesBiopsyChild, PreschoolHematuriaHumansKidneyMaleNephrotic SyndromePrednisoloneProteinuriaTreatment OutcomePrednisoloneMembranous nephropathyNephrotic syndromePrednisoloneVEO-IBD

Identifiers

PMID42315775
PMCPMC13280327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.